Efficacy of Afatinib in a Previously-Treated Patient with Non-Small Cell Lung Cancer Harboring HER2 Mutation: Case Report

Những quyển sách tương tự

• A Phase II Trial of Osimertinib as the First-Line Treatment of Non–Small Cell Lung Cancer Harboring Activating EGFR Mutations in Circulating Tumor DNA: LiquidLung-O-Cohort 1
  Bằng: Park, Cheol-Kyu, et al.
  Được phát hành: (2021)
• Potentially fatal complications of systemic air embolism after computed tomography‐guided transthoracic needle biopsy in lung cancer harboring epithelial growth factor receptor mutation: A case report
  Bằng: Oh, Hyung‐Joo, et al.
  Được phát hành: (2020)
• Predictive factors for long‐term responders of pemetrexed maintenance treatment in non‐small cell lung cancer
  Bằng: Yoon, Joon‐Young, et al.
  Được phát hành: (2019)
• A Phase II Trial of Osimertinib in the Second-Line Treatment of Non-small Cell Lung Cancer with the EGFR T790M Mutation, Detected from Circulating Tumor DNA: LiquidLung-O-Cohort 2
  Bằng: Park, Cheol-Kyu, et al.
  Được phát hành: (2019)
• Co-alteration of EGFR mutation and ALK rearrangement in non-small cell lung cancer: Case series
  Bằng: Shin, Hong-Joon, et al.
  Được phát hành: (2019)